Effect of Alkyl Chain Length on Physicochemical and Pharmacokinetic Performance of Aripiprazole Fatty Acid Prodrugs for Long-Acting Injectable Suspensions

Background/Objectives: Long-acting injectable aqueous suspensions based on fatty acid prodrugs offer a compelling strategy for chronic disease management. However, the selection of optimal alkyl chain length remains largely empirical, as its influence on prodrug performance is highly system-dependent and lacks predictive guidelines. Methods: Three aripiprazole prodrugs with different alkyl chain lengths were synthesized and characterized using 1H-NMR spectroscopy and single-crystal X-ray diffraction. A series of physicochemical assessments was performed, including melting point, solubility, lipophilicity, solid-state stability, and plasma stability. The prodrugs were subsequently formulated as aqueous suspensions, which were evaluated for particle size, morphology, release behavior, cytotoxicity, and cellular uptake. Finally, intramuscular administration in rats was carried out to investigate pharmacokinetic profiles and local tolerability. Results: Physicochemical characterization revealed that chain elongation progressively reduced the melting point, solubility, wettability, and solid-state stability of these prodrugs, whereas their flexibility, lipophilicity, and plasma stability correspondingly increased. After wet milling and intramuscular administration in rats, all suspensions sustained drug release for up to one month with good tolerability. Notably, the aripiprazole lauroxil formulation exhibited superior bioavailability and a shortened subtherapeutic interval, enabling the rapid attainment of therapeutic concentrations while effectively mitigating a prolonged pharmacokinetic tail. Conclusions: These findings reinforce the favorable profile of aripiprazole lauroxil as a lead candidate and demonstrate that isostructural packing facilitates the reliable prediction of chain length–property correlations across diverse fatty acid-prodrug systems, thus providing a valuable reference for rational alkyl chain selection in the design of fatty acid-based LAI suspensions.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2026-07-24
DOI
https://doi.org/10.3390/pharmaceutics18080911
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of Alkyl Chain Length on Physicochemical and Pharmacokinetic Performance of Aripiprazole Fatty Acid Prodrugs for Long-Acting Injectable Suspensions

Ting Cai, Xicheng Zhang, Y Zhang, An Chen et al.
Pharmaceutics
Drug Solubulity and Delivery Systems
article

Effect of Alkyl Chain Length on Physicochemical and Pharmacokinetic Performance of Aripiprazole Fatty Acid Prodrugs for Long-Acting Injectable Suspensions

Ting Cai, Xicheng Zhang, Y Zhang, An Chen, Cong Lai, Hao Zhai
article en

Abstract

Background/Objectives: Long-acting injectable aqueous suspensions based on fatty acid prodrugs offer a compelling strategy for chronic disease management. However, the selection of optimal alkyl chain length remains largely empirical, as its influence on prodrug performance is highly system-dependent and lacks predictive guidelines. Methods: Three aripiprazole prodrugs with different alkyl chain lengths were synthesized and characterized using 1H-NMR spectroscopy and single-crystal X-ray diffraction. A series of physicochemical assessments was performed, including melting point, solubility, lipophilicity, solid-state stability, and plasma stability. The prodrugs were subsequently formulated as aqueous suspensions, which were evaluated for particle size, morphology, release behavior, cytotoxicity, and cellular uptake. Finally, intramuscular administration in rats was carried out to investigate pharmacokinetic profiles and local tolerability. Results: Physicochemical characterization revealed that chain elongation progressively reduced the melting point, solubility, wettability, and solid-state stability of these prodrugs, whereas their flexibility, lipophilicity, and plasma stability correspondingly increased. After wet milling and intramuscular administration in rats, all suspensions sustained drug release for up to one month with good tolerability. Notably, the aripiprazole lauroxil formulation exhibited superior bioavailability and a shortened subtherapeutic interval, enabling the rapid attainment of therapeutic concentrations while effectively mitigating a prolonged pharmacokinetic tail. Conclusions: These findings reinforce the favorable profile of aripiprazole lauroxil as a lead candidate and demonstrate that isostructural packing facilitates the reliable prediction of chain length–property correlations across diverse fatty acid-prodrug systems, thus providing a valuable reference for rational alkyl chain selection in the design of fatty acid-based LAI suspensions.

PharmaceuticsVol. 18(8)
China Pharmaceutical University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 10%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.